MBOT NASDAQ
Microbot Medical Inc.
1W: +8.7%
1M: -17.6%
3M: -38.3%
YTD: -51.2%
1Y: -57.4%
3Y: -22.6%
5Y: -85.8%
$1.03
+0.09 (+9.38%)
Weekly Expected Move ±6.2%
$1
$1
$1
$1
$1
Credit Risk of going bust: lower than 65% of companies Debt: 1.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down 99.8%), Microbot Medical Inc. would be worth roughly what it owes.
Total debt $876K against a stock market value of $69.2M.
Distance to default 6.84 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $601K (short-term plus half of long-term), stock volatility 67.4%; Altman Z 7.58. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down 99.8%), Microbot Medical Inc. would be worth roughly what it owes.
Total debt $876K against a stock market value of $69.2M.
Distance to default 6.84 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $601K (short-term plus half of long-term), stock volatility 67.4%; Altman Z 7.58. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
-0.45
Bearish
0 bullish
1 neutral
1 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (39)
FY2027 EPS Forecast for Microbot Medical Lowered by Analyst
Microbot Medical Inc. (NASDAQ:MBOT) Stock Has Average Target Price of $6.38 According to Analysts
Microbot Medical Inc. (NASDAQ:MBOT) Receives $6.38 Average PT from Analysts
Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates
New Strong Buy Stocks for July 23rd
Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System
Why $MBOT is about to explode.. A whole new class of medical robots at an absolute steal!
Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations
Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System
After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT)
Microbot Medical plunges amid results, short report from White Diamond Research
Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates
Cencora to Report Q2 Earnings: What's in Store for the Stock?
Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites
Solventum to Post Q1 Earnings: Is a Beat Likely for the Stock?
DENTSPLY SIRONA to Post Q1 Earnings: What's in Store for the Stock?
Can Strong Growth Aid INNV's Q3 Earnings Amid Margin Seasonality?
Revvity to Report Q1 Earnings: What's in Store for the Stock?
Stryker to Report Q1 Earnings: What's in Store for the Stock?
Will DXCM's G7 Uptake Continue to Drive Top-line Growth in Q1?
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
Q1 EPS Forecast for Microbot Medical Increased by Analyst
Microbot Medical Begins Full U.S. Launch of LIBERTY System
Microbot Medical (NASDAQ:MBOT) Shares Pass Above 200-Day Moving Average – Time to Sell?
Microbot Medical Inc. (NASDAQ:MBOT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System
Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
Microbot Medical Inc. $MBOT Shares Purchased by CIBC Private Wealth Group LLC
Microbot Medical® to Participate at the 38th Annual Roth Conference
Microbot Medical (NASDAQ:MBOT) Stock Price Crosses Above 200-Day Moving Average – Here’s What Happened
Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time
Microbot Medical Inc. (NASDAQ:MBOT) Receives Consensus Rating of “Moderate Buy” from Analysts
Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation
Microbot Medical Inc. (NASDAQ:MBOT) Short Interest Update
Microbot Medical says no impact from geopolitical events
Microbot Medical®'s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference
Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption
Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones
Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System